Shanghai Ovarian Cancer and Family Care Project

NCT06118307 · tracked via the Priya Life Science China tracker

Sponsor

Shanghai First Maternity and Infant Hospital

Phase

Observational

Started

2013-01-01

Last updated

2023-11-07

Condition(s) studied

Ovarian Cancer

Study summary

Ovarian cancer is the most lethal gynaecological malignancy, but its incidence in the general population is low. Due to the lack of effective prevention and successful screening approaches, most cases are diagnosed at advanced stages, leading to poor prognosis. In order to address the research requirements pertaining to ovarian cancer, the Shanghai Ovarian Cancer and Family Care Project was established. This initiative offers hospital-based resources for investigating ovarian cancer and high-risk populations. The project comprises an on-going ovarian cancer cohort, a high-risk population cohort, and a healthy population cohort. By leveraging these comprehensive cohorts, the project provides a unique platform for in-depth studies on the detection, prevention, early diagnosis, treatment, and prognosis of ovarian cancer.

Eligibility

Sex

FEMALE

Min age

18 Years

Max age

—

Healthy volunteers

Accepted

Participant meet the criteria for one of the following conditions: * Patients attending the oncology department require differential diagnosis of ovarian cancer. * Patients with known high-risk factors for ovarian cancer, such as history of ovarian cancer or BRCA-associated cancer, etc. * Patients attending the Physical Examination Center who have normal findings on physical examination and no symptoms. Exclusion Criteria: * Individuals with evidence of another active cancer. * Individuals who have prior bilateral oophorectomy. * Individuals who are unwilling or unable to sign the informed consent form.

Primary outcome measure(s)

Death due to ovarian cancer — From diagnosis of ovarian cancer until October 31, 2028.
Death due to ovarian cancer determined by independent outcomes committee.

Trial sites (1)

Facility	City	Region	Status
Shanghai first maternity and infant hospital	Shanghai	Shanghai Municipality	Recruiting

More Shanghai First Maternity and Infant Hospital trials in China

Effect of Hysteroscopic Metroplasty on Reproductive Outcome in Patients with RIF Enrolling by invitation

Feasibility Effects of a Low-GI, High-fibre Diet in PCOS: a Prospective Cohort Study in Remote Yunnan Recruiting

Other trials for the same condition

A Study of LBL-024 in Combination With Paclitaxel ± Bevacizumab for the Treatment of Platinum-resistant Ovarian Cancer Recruiting

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer Recruiting

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors Recruiting

A Biomarker Exploration Study of Precision Treatment in Ovarian Cancer Active, not recruiting

Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06118307 on ClinicalTrials.gov ↗ ← All trials in China